JPRN-UMIN000004280已完成未知
Phase II study of dasatinib for CML-CP patients with suboptima/failure after treatment of imatinib - Fukuoka CML stem cell study
Fukuoka CML stem cell research group0 个研究点目标入组 20 人开始时间: 2010年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •CML-BC and AP
研究者
相似试验
已完成
不适用
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life SettingChronic Myeloid LeukemiaNCT04089839Bristol-Myers Squibb177
已完成
2 期
Dasatinib Therapy Aiming for TFR in Patients with CML-CPchronic myeloid leukemia in chronic phaseJPRN-jRCTs031180332Yoshida Chikashi181
已完成
2 期
Phase II Clinical Trial of Dasatinib Therapy Aiming for Treatment-Free Remission in Patients with Chronic Phase Chronic Myeloid LeukemiaChronic Phase Chronic Myeloid LeukemiaJPRN-UMIN000022254Kanto CML Study Group181
已完成
不适用
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failureChronic Myeloid Leukemia (chronic phase)JPRN-UMIN000001900Inter-Michinoku Dasatinib Study(IMIDAS)60
招募中
不适用
Stop imatinib or dasatinib study in CP-CML patients mainitaining complete molecular response for two yearschronic phase chronic myeloid leukemiaJPRN-UMIN000007944Tokyo Women's Medical University40